Research
Metabolic adaptation
INV-202 exhibited significant reductions in waist circumference and BMI (P ≤ 0.03).
INV-202 may help reduce waist circumference and BMI in this population.
StrongSupportsmedium confidence
INV-202 also exhibited significant reductions in waist circumference and BMI (P ≤ 0.03).
Why this rating
Based on study design from abstract.
Source
Effects of <scp>CB1R</scp> inverse agonist, <scp>INV</scp> ‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study
Glenn Crater et al. · Diabetes Obesity and Metabolism · 2023
rct · n=37Cited 40×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →